Studies demonstrate that RNF115 mediates p53 ubiquitination to predict poor prognosis in patients with lung adenocarcinoma, and RNF115-p53 axis might be an effective therapeutic target of LC (65). The gene discussed is TP53; the disease is lung adenocarcinoma.